David Fontana

Company: Umoja BioPharma

Job title: Chief Business & Strategy Officer

Seminars:

Panel Discussion: Changing the Face of Cell Therapies with In Vivo Gene Engineering 3:00 pm

Exploring the potential to develop a universal cell therapy without ex vivo isolation/expansion of T-cells How can we improve safety, dosing and efficacy by using mRNA to create CAR-T cells in vivo? Discussing how to control the pharmacokinetic properties of the cell productRead more

day: Day 1 – Track A – Afternoon

Attacking Solid Tumours with an Integrated Approach of Universal Tumour Tags & In Vivo Transduced CARs 2:30 pm

Cell therapy progress in hematological tumours is transformational however solid tumours still a remain a challenge Novel targeting both tumour cells and local stromal cells will be discussed Tumour tagging along with in vivo CAR transduction offers a unique solution to known issues current approachesRead more

day: Day 1 – Track A – Afternoon